Evidence map›Paper›PMID 27835923›Full record

ReviewAntioxidants & redox signaling2017

Reactive Oxygen Species/Nitric Oxide Mediated Inter-Organ Communication in Skeletal Muscle Wasting Diseases.

Lucia M Leitner, Rebecca J Wilson, Zhen Yan, Axel Gödecke

Abstract readReview
In one paragraph

Review in Antioxidants & redox signaling, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 48 citations in OpenAlex.

  1. PasteurizedNutrients · 2024
    Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Antioxidants (Basel, Switzerland) · 2021
    Article
  16. Article
  17. Review
  18. Review
  19. Autophagy and metabolism.The Kaohsiung journal of medical sciences · 2021
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Lucia M Leitner1 Institut für Herz- und Kreislaufphysiologie, Heinrich-Heine-Universität Düsseldorf, Universitätsklinikum , Düsseldorf, Germany .
Rebecca J Wilson2 Department of Medicine-Cardiovascular Medicine, University of Virginia , Charlottesville, Virginia.
Zhen Yan2 Department of Medicine-Cardiovascular Medicine, University of Virginia , Charlottesville, Virginia.
Axel Gödecke1 Institut für Herz- und Kreislaufphysiologie, Heinrich-Heine-Universität Düsseldorf, Universitätsklinikum , Düsseldorf, Germany .
University of Virginia · US

Funding

p38 MAPK a regulator of muscle contraction and functionR01AR050429 · NIAMS · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI YAN, ZHEN · 2005 to 2022
$5.3M
Transient behaviors of adapting biological systemsR01GM100473 · NIGMS · RUTGERS, THE STATE UNIV OF N.J. · PI SONTAG, EDUARDO · 2011 to 2014
$1.6M
Muscle-mediated protection against MODSR01GM114840 · NIGMS · UNIVERSITY OF VIRGINIA · PI YAN, ZHEN · 2015 to 2018
$1.2M
NO-dependent SOD3 protection against cachexiaR21AR060444 · NIAMS · UNIVERSITY OF VIRGINIA · PI YAN, ZHEN · 2011 to 2012
$381k
NIAMS NIH HHS R01 AR050429NIAMS NIH HHS R21 AR060444NIGMS NIH HHS R01 GM100473NIGMS NIH HHS R01 GM114840
6 · The paper itself

Abstract

significanceCachexia is defined as a complex metabolic syndrome that is associated with underlying illness and a loss of muscle with or without loss of fat mass. This disease is associated with a high incidence with chronic diseases such as heart failure, cancer, chronic obstructive pulmonary disease (COPD), and acquired immunodeficiency syndrome (AIDS), among others. Since there is currently no effective treatment available, cachectic patients have a poor prognosis. Elucidation of the underlying mechanisms is, therefore, an important medical task. Recent Advances: There is accumulating evidence that the diseased organs such as heart, lung, kidney, or cancer tissue secrete soluble factors, including Angiotensin II, myostatin (growth differentiation factor 8 [GDF8]), GDF11, tumor growth factor beta (TGFβ), which act on skeletal muscle. There, they induce a set of genes called atrogenes, which, among others, induce the ubiquitin-proteasome system, leading to protein degradation. Moreover, elevated reactive oxygen species (ROS) levels due to modulation of NADPH oxidases (Nox) and mitochondrial function contribute to disease progression, which is characterized by loss of muscle mass, exercise resistance, and frailty. CRITICAL ISSUES: Although substantial progress was achieved to elucidate the pathophysiology of cachexia, effectice therapeutic strategies are urgently needed. FUTURE DIRECTIONS: With the identification of key components of the aberrant inter-organ communication leading to cachexia, studies in mice and men to inhibit ROS formation, induction of anti-oxidative superoxide dismutases, and upregulation of muscular nitric oxide (NO) formation either by pharmacological tools or by exercise are promising approaches to reduce the extent of skeletal muscle wasting. Antioxid. Redox Signal. 26, 700-717.

Indexed as

AnimalsHumansMuscle, SkeletalNitric OxideReactive Oxygen SpeciesWasting SyndromeNitric OxideReactive Oxygen Speciesangiotensinautophagycachexiaexerciseskeletal muscleubiquitin

Identifiers

PMID27835923
PMCPMC5421600
OpenAlexW2557011447

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.